Radionuclide Imaging for the Detection of Inflammation in Vulnerable Plaques
John R. Davies, BSc, MBBS, MRCP*,
James H.F. Rudd, PhD, MRCP ,
Peter L. Weissberg, MD, FRCP*,* and
Jagat Narula, MD, PhD, FACC
* Addenbrookes Hospital, University of Cambridge, Cambridge, United Kingdom
Imaging Science Laboratory, Mount Sinai Hospital, New York, New York
University of California-Irvine School of Medicine, Irvine, California
Manuscript received June 16, 2005;
revised manuscript received October 10, 2005,
accepted November 16, 2005.
* Reprint requests and correspondence: Dr. Peter L. Weissberg, Division of Cardiovascular Medicine, Box 110, Level 6 ACCI, Addenbrookes Hospital, Hills Road, Cambridge CB2 2QQ, United Kingdom (Email: weissbergp{at}bhf.org.uk).
Imaging of atheromatous plaques has traditionally centered on assessing the degree of luminal stenosis. More recently it has become clear that the vulnerable atherosclerotic plaques responsible for the majority of life-threatening syndromes are characterized by high numbers of inflammatory cells and proteins. This has highlighted the urgent need for suitable imaging techniques that can identify and quantify levels of inflammation within atheromatous lesions. Positron emission tomography and single-photon emission computed tomography imaging hold promise in this regard. Tracer compounds capable of assessing macrophage recruitment, foam cell generation, matrix metalloproteinase production, macrophage apoptosis, and macrophage metabolism have been developed and tested in the carotid and peripheral circulation. The identification of inflamed lesions within the coronary circulation, however, remains elusive owing to small plaque size, cardiac and respiratory motion, and lack of a suitable specific nuclear tracer.
|
Abbreviations and Acronyms
| | CT = computed tomography | | FDG = fluorine-18labeled deoxyglucose | | HO-CGS 27023A = 123I-labeled molecule | | MCP-1 = monocyte chemotactic protein-1 | | MDA2 = malondialdehyde-2 | | MMP = matrix metalloproteinase | | MRI = magnetic resonance imaging | | oxLDL = oxidized low-density lipoprotein | | PET = positron emission tomography | | PS = phosphatidyl serine | | SPECT = single-photon emission computed tomography | | Tc = technetium | | TIA = transient ischemic attack | | WHHL = Wantanabe heritable hyperlipidemic |
|
This article has been cited by other articles:

|
 |

|
 |
 
M. J. Lipinski, J. C. Frias, V. Amirbekian, K. C. Briley-Saebo, V. Mani, D. Samber, A. Abbate, J. G. S. Aguinaldo, D. Massey, V. Fuster, et al.
Macrophage-Specific Lipid-Based Nanoparticles Improve Cardiac Magnetic Resonance Detection and Characterization of Human Atherosclerosis.
J. Am. Coll. Cardiol. Img.,
May 1, 2009;
2(5):
637 - 647.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Calcagno, J.-C. Cornily, F. Hyafil, J. H.F. Rudd, K. C. Briley-Saebo, V. Mani, G. Goldschlager, J. Machac, V. Fuster, and Z. A. Fayad
Detection of Neovessels in Atherosclerotic Plaques of Rabbits Using Dynamic Contrast Enhanced MRI and 18F-FDG PET
Arterioscler. Thromb. Vasc. Biol.,
July 1, 2008;
28(7):
1311 - 1317.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. C. Briley-Saebo, P. X. Shaw, W. J.M. Mulder, S.-H. Choi, E. Vucic, J. G. S. Aguinaldo, J. L. Witztum, V. Fuster, S. Tsimikas, and Z. A. Fayad
Targeted Molecular Probes for Imaging Atherosclerotic Lesions With Magnetic Resonance Using Antibodies That Recognize Oxidation-Specific Epitopes
Circulation,
June 24, 2008;
117(25):
3206 - 3215.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Vesely and V. Dilsizian
Nuclear Cardiac Stress Testing in the Era of Molecular Medicine
J. Nucl. Med.,
March 1, 2008;
49(3):
399 - 413.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. S. Dunphy, H. Schoder, and H. W. Strauss
Radionuclide Techniques for Identifying Vulnerable Plaque
J. Nucl. Med.,
November 1, 2007;
48(11):
1753 - 1755.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. A. Jaffer, P. Libby, and R. Weissleder
Molecular Imaging of Cardiovascular Disease
Circulation,
August 28, 2007;
116(9):
1052 - 1061.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-W. Wu, H.-L. Kao, M.-F. Chen, B.-C. Lee, W.-Y. I. Tseng, J.-S. Jeng, K.-Y. Tzen, R.-F. Yen, P.-J. Huang, and W.-S. Yang
Characterization of Plaques Using 18F-FDG PET/CT in Patients with Carotid Atherosclerosis and Correlation with Matrix Metalloproteinase-1
J. Nucl. Med.,
February 1, 2007;
48(2):
227 - 233.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|